Shifting Perceptions of CRISPR
Photo by National Cancer Institute on Unsplash INTRODUCTION More than 20 cell and gene therapies are now available to safely minimize genetic diseases such as retinal dystrophy (LUXTURNA), some B-cell lymphomas (YESCARTA), and B-cell lymphoblastic leukemia (KYMRIAH).[1] One such gene-ed...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia University Libraries
2021-08-01
|
Series: | Voices in Bioethics |
Subjects: | |
Online Access: | https://journals.library.columbia.edu/index.php/bioethics/article/view/8595 |